Ashley Bass, APRN
Adult Health · Aiken, SCNPI 1194097444
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,561 of the $6,683 with a category attached, or 68.3%. 35 manufacturers reported payments, led by Abbott at 34.7% of the total. Among adult health clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $29.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Merck$667
- AstraZeneca$658
- Novartis$318
- Boehringer Ingelheim$270
- Cvrx, Inc.$259
- plus $2K from 29 others
What the payments were for
- Consulting fees$2,10031%
- Food & beverage$4,56168%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $2,319 |
| Merck | 37 | $667 |
| AstraZeneca | 28 | $658 |
| Novartis | 18 | $318 |
| Boehringer Ingelheim | 13 | $270 |
| Cvrx, Inc. | 9 | $259 |
| Pfizer | 14 | $254 |
| Boston Scientific | 9 | $249 |
| E.r. Squibb & Sons, L.L.C. | 12 | $191 |
| Abiomed | 3 | $139 |
| Actelion Pharmaceuticals US, Inc. | 6 | $138 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $127 |
| Scpharmaceuticals Inc. | 6 | $121 |
| Astellas Pharma US Inc | 8 | $113 |
| Lexicon Pharmaceuticals, Inc. | 6 | $112 |
| Johnson & Johnson | 5 | $76 |
| Bridgebio Pharma, Inc. | 3 | $74 |
| Novo Nordisk | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $59 |
| Medtronic | 3 | $55 |
| Bayer | 3 | $51 |
| Stryker | 2 | $41 |
| Amgen | 3 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Inari Medical, Inc. | 1 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Solventum Corporation | 1 | $17 |
| Hydrofera LLC | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Bard Peripheral Vascular, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CardioMEMS HF System$2,100
- WAINUA$125
- Barostim Neo System$124
How this compares
$6,683 in reported general payments places this provider in the 90th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 756 | $777,407 |
| CamzyosMavacamten | 45 | $377,384 |
| JardianceEmpagliflozin | 394 | $367,358 |
| FarxigaDapagliflozin Propanediol | 380 | $341,960 |
| EliquisApixaban | 235 | $231,342 |
| VerquvoVericiguat | 44 | $45,501 |
| Droxidopa | 11 | $20,784 |
| XareltoRivaroxaban | 21 | $17,754 |
| BrilintaTicagrelor | 16 | $16,695 |
| Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine | 21 | $8,278 |
| DapagliflozinDapagliflozin Propanediol | 11 | $5,517 |
| Metoprolol Succinate | 312 | $3,697 |
| Spironolactone | 381 | $3,022 |
| Torsemide | 95 | $2,537 |
| Carvedilol | 255 | $2,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $318 | $777,407756 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $191 | $377,38445 claims |
| Boehringer IngelheimJardiance | $270 | $367,358394 claims |
| AstraZenecaFarxiga, Brilinta | $658 | $358,655396 claims |
| PfizerEliquis | $254 | $231,342235 claims |
| MerckVerquvo | $667 | $45,50144 claims |
| Johnson & JohnsonXarelto | $76 | $17,75421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 292 adult health providers in South Carolina.
Other adult health in Aiken
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
- Christi WigginsWest Columbia$10K
- Mary BairdSumter$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.